BankPlus Trust Department’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.8K Sell
164
-1,033
-86% -$83.3K ﹤0.01% 377
2026
Q1
$104K Buy
1,197
+988
+473% +$94.6K 0.03% 221
2025
Q4
$20.1K Hold
209
– – 0.01% 325
2025
Q3
$19.9K Hold
209
– – 0.01% 320
2025
Q2
$18.2K Sell
209
-55
-21% -$4.66K 0.01% 311
2025
Q1
$23.7K Hold
264
– – 0.01% 291
2024
Q4
$21.1K Buy
+264
New +$22.9K 0.01% 292

Other funds holding MDT

BankPlus Trust Department's MDT Position: Q2 2026 in Review

BankPlus Trust Department reduced its Medtronic (MDT) stake by 86% in Q2 2026, selling an estimated $83.3K and leaving 164 shares worth $12.8K. The position accounts for ﹤0.01% of the portfolio, ranked #377.

BankPlus Trust Department first reported a position in MDT in Q4 2024 and has held it in 7 quarters since. The position peaked at $104K in Q1 2026. 2,146 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • BankPlus Trust Department held 164 shares of Medtronic worth $12.8K as of Q2 2026.
  • BankPlus Trust Department sold 1,033 Medtronic shares in Q2 2026, an estimated $83.3K.
  • Medtronic made up ﹤0.01% of BankPlus Trust Department's portfolio in Q2 2026, its #377 holding.
  • BankPlus Trust Department first reported a position in Medtronic in Q4 2024 and has held it in 7 quarters since.
  • BankPlus Trust Department's Medtronic position peaked at $104K in Q1 2026.
  • 2,146 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on BankPlus Trust Department's 13F filing for Q2 2026, filed 28 Jul 2026.